Screener
Artiva Biotherapeutics, Inc. ARTV Short-Term Investments
Short-Term Investments at other companies
Other financials
Where this comes from
Reported directly by Artiva Biotherapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ShortTermInvestments.
The source filing: Artiva Biotherapeutics, Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:12 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-338029
| Line item | AS OF / JUNE 30,2026 | AS OF / DECEMBER 31,2025 |
|---|---|---|
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $301,454 | $26,701 |
| Short-term investments | 47,940 | 81,307 |
| Other receivables (including related party amounts of $0 and $61, respectively) | 141 | 67 |
| Prepaid expenses and other current assets | 2,741 | 4,591 |
| Total current assets | 352,276 | 112,666 |
| Restricted cash | 461 | 461 |
Item 1. Financial Statements
FAQ
- What is Artiva Biotherapeutics, Inc.'s short-term investments?
- Artiva Biotherapeutics, Inc. (ARTV) reported short-term investments of $47.94M in Q2 2026.
- How has Artiva Biotherapeutics, Inc.'s short-term investments changed year-over-year?
- Artiva Biotherapeutics, Inc.'s short-term investments decreased by 57.9% year-over-year, from $113.9M to $47.94M.
- What is the long-term trend for Artiva Biotherapeutics, Inc.'s short-term investments?
- Over 2 years (2023 to 2025), Artiva Biotherapeutics, Inc.'s short-term investments has grown at a 86.1% compound annual growth rate (CAGR), from $23.47M to $81.31M.
- What does short-term investments mean?
- Marketable securities and other investments with maturities between three months and one year, providing yield above cash while maintaining liquidity.
Ask your AI about Artiva Biotherapeutics, Inc.'s short-term investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude